Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.
This report contains market size and forecasts of Cox-2 Inhibitors in Global, including the following market information:
Global Cox-2 Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cox-2 Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Selective Cox-2 Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cox-2 Inhibitors include Bayer, Novartis, Pfizer, Merck, Cadila Pharmaceuticals and Sabinsa Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cox-2 Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cox-2 Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cox-2 Inhibitors Market Segment Percentages, by Type, 2021 (%)
Selective Cox-2 Inhibitors
Non Selective Cox-2 Inhibitors
Global Cox-2 Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cox-2 Inhibitors Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Cox-2 Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cox-2 Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cox-2 Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cox-2 Inhibitors revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation